Add Yahoo as a preferred source to see more of our stories on Google. “It's not always easy to share images/videos of my body, but I know it's always worth it,” the fitness influencer said Lexi Reed ...

Fitness influencer Lexi Reed celebrated a major milestone in her recovery from calciphylaxis, sharing that it had been one year since she’d had her last infusion for the disease. “ONE YEAR TODAY SINCE ...

Last year, the weight loss influencer was diagnosed with calciphylaxis, a rare condition that left her hospitalized and unable to walk or stand on her own for months Vanessa Etienne is a Staff Writer ...

“I dreamed of a day my legs would even allow me to walk back into a gym,” the fitness influencer said Lexi Reed/Instagram Lexi Reed is officially back in the gym! On Tuesday, the fitness influencer ...

Intravenous sodium thiosulphate flopped for treating calciphylaxis in people with chronic kidney disease (CKD), researchers reported. In a systematic review and meta-analysis, there was no significant ...

The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular diseases in patients with CKD are unique and grouped as uremic vascular ...

close up of bruise hit in the leg Author reviews calciphylaxis incidence, risk factors, pathogenesis, differential diagnoses, and treatment. A 54-year-old man presents to a hospice inpatient unit for ...

Recognises the potential of Aurase Wound Gel to improve outcomes for individuals with calciphylaxis ulcers, a rare and life-threatening condition Represents a new indication for Aurase Wound Gel, ...

Vials of drug Currently, there is no approved therapy for calciphylaxis. Intravenous sodium thiosulfate does not improve skin lesions or reduce the risk of dying from calciphylaxis, a rare but ...

Although intravenous sodium thiosulfate (IV STS) is considered standard care in the treatment of calciphylaxis, HBOT has been reported to have beneficial effects. Researchers retrospectively reviewed ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced that the US Food and Drug Administration (FDA) has granted Fast ...